Foley Partner David Rosen was quoted in an article that appeared in CNNMoney on August 24, 2010 titled “Recall fallout: FDA puts execs on notice.” Rosen discusses increased efforts by the Food and Drug Administration to identify and potentially prosecute executives at companies that have issued a number of recalls due to manufacturing violations. He states that the FDA is developing a tougher compliance attitude because companies are ignoring warnings from the agency, adding that it appears the FDA wants to send a clearer message regarding regulation and compliance.
People
Related News
July 28, 2025
In the News
Mark Wolfson Honored in Florida Bar Spotlight
Foley & Lardner LLP partner Mark Wolfson was featured by The Florida Bar for his contributions to the Florida legal community in a "Past Chair Spotlight."
July 24, 2025
In the News
Margaret Nelson Assesses SEC Enforcement Philosophy
Foley & Lardner LLP partner Margaret Gembala Nelson commented in the Private Equity Law Report article, "SEC Enforcement Action Raises Potential Materiality Threshold for Conflicts of Interest," sharing insight on enforcement philosophy at the U.S. Securities and Exchange Commission.
July 24, 2025
In the News
Foley's Trial Team Featured Following Landmark Victory in Texas Trade Secret Case
Foley & Lardner LLP’s recent landmark appellate victory in a Texas trade secrets case is featured in the Texas Lawyer article, "Ruling Sets Precedent for Employment, Trade Secrets, Fiduciary Duty."